A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

NCT06034743 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

796

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Hypertension
Resistant Hypertension

Interventions

DRUG: Baxdrostat
DRUG: Placebo

Sponsor

AstraZeneca